Skip to content

MAZE MAZE Debt-to-equity

Debt-to-equity at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
0.1×0.0×
Septerna, Inc. logo
Septerna, Inc.SEPN
0.1×
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
0.0×
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
0.0×
Zymeworks logo
ZymeworksZYME
0.1×0.0×
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
0.1×+0.1×

Other financials

Income statement

See full
Revenue$20.0M
Operating income-$26.6M+25.0%
Net income-$24.2M+26.2%
EPS (diluted)-$0.45+60.9%

Balance sheet

See full
Cash & equivalents$198.8M-32.5%
Total debt$61.2M+137%
Total equity$341.7M+17.0%
Total assets$419.7M+26.1%

Cash flow

See full
Operating cash flow-$39.1M-32.5%
CapEx$93.0K-68.9%
Free cash flow-$39.2M-31.5%

Valuation

See full
Market cap$1.48B
Enterprise value$1.34B
P/S7.9×

Profitability

See full
Operating margin-71.5%
Net margin-65.4%
FCF margin-65.1%

Returns & leverage

See full
Return on equity-38.7%
Current ratio17.9×+1.8×

Where this comes from

Calculated from MAZE’s reported figures.

Based on the most recent quarter.

The official record: MAZE’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about MAZE's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MAZE's debt-to-equity?
MAZE (MAZE) reported debt-to-equity of 0.2× in Q1 2026.
How has MAZE's debt-to-equity changed year-over-year?
MAZE's debt-to-equity increased by 102.7% year-over-year, from 0.1× to 0.2×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.